Xtent (MM)
   
To register click here

Xtent Stock Price XTNT

Company Description : A development stage medical device company, which focused on developing and commercializing its customizable drug eluting stent systems for the treatment of coronary artery disease or CAD. url: www.xtentinc.com

Name:
Xtent (MM)
Symbol:
NASDAQ:XTNT
Stock Market:
NASDAQ Stock Market
Type:
Common Stock
ISIN:
Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
0.00.002.722.263.152.722.72.7550016:40:56
To register Click hereRegister for free Xtent stock prices.

XTENT Appoints Christopher M. Smith and Arthur T. Taylor to Board of Directors : MENLO PARK, Calif., June 20 /PRNewswire-FirstCall/ -- XTENT, Inc. (NASDAQ:XTNT) announced today that Christopher M. Smith and Arthur T. Taylor have been appointed to the company's board of directors. "We expect to benefit...

Free Xtent Stock Charts

Xtent Historical Stock Chart
Xtent Historical Stock Chart
Xtent Monthly Stock Chart
Xtent Monthly Stock Chart
Xtent Intraday stock chart
Xtent Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest Xtent stock Price, quotes, trades and FREE Xtent stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Xtent (XTNT) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Xtent News

Latest Xtent News Headlines
DateTimeSource
Headline
06/20/20088:00AMPRNUSXTENT Appoints Christopher M. Smith and Arthur T. Taylor to Board of Directors
06/17/20088:30AMPRNUSXTENT Announces CUSTOM I Data Receives Recognition from EuroIntervention
06/12/20084:39PMPRNUSXTENT Announces European Regulatory Update
05/13/200812:21PMTFNFXtent reports 'positive' six-month follow-up data on custom stent trial
05/13/200811:40AMPRNUSXTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
05/07/20088:30AMPRNUSXTENT Announces Clinical Trial Data to be Presented at Annual EuroPCR Meeting Next Week
04/28/20087:05PMPRNUSXTENT Announces First Quarter 2008 Financial Results
03/12/20088:30AMPRNUSXTENT to Present at Cowen and Company's 28th Annual Health Care Conference
02/19/20084:05PMPRNUSXTENT Announces 2007 Financial Results
02/12/20084:05PMPRNUSXTENT Announces 2007 Financial Results Conference Call
12/27/20076:00AMPRNUSXTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
11/15/20078:30AMPRNUSXTENT to Present at Three Upcoming Investor Conferences

Xtent Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Xtent company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Xtent Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  100 2.72 07/25/2008 3:52PM USD


 



PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
31 site:2us nasdaq xtnt080725 18:12 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )